Frankfurt - Delayed Quote
EUR
BioNxt Solutions Inc. (BXT.F)
0.2200
+0.0520
(+30.95%)
As of 10:13:35 AM GMT+2. Market Open.
Loading chart for BXT.F
- Previous Close
0.1680 - Open
0.1850 - Bid 0.1705 x --
- Ask 0.2200 x --
- Day's Range
0.1850 - 0.2200 - 52 Week Range
0.1680 - 0.5540 - Volume
2,050 - Avg. Volume
10,298 - Market Cap (intraday)
29.932M - Beta (5Y Monthly) 1.42
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0400 - Earnings Date (est.) --
- Forward Dividend & Yield -- (0.00%)
- Ex-Dividend Date --
- 1y Target Est
--
Recent News
View MorePerformance Overview
Trailing total returns as of 10/19/2026, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .
YTD Return
BXT.F
47.62%
S&P/TSX Composite index (^GSPTSE)
13.53%
1-Year Return
BXT.F
58.02%
S&P/TSX Composite index (^GSPTSE)
20.15%
3-Year Return
BXT.F
18.92%
S&P/TSX Composite index (^GSPTSE)
86.97%
5-Year Return
BXT.F
72.60%
S&P/TSX Composite index (^GSPTSE)
71.56%
Earnings Trends
View MoreStatistics
View MoreValuation Measures
As of 5/8/2026
-
Market Cap
34.65M
-
Enterprise Value
38.06M
-
Trailing P/E
--
-
Forward P/E
--
-
PEG Ratio (5yr expected)
--
-
Price/Sales (ttm)
3.23k
-
Price/Book (mrq)
--
-
Enterprise Value/Revenue
4.28k
-
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
-
Profit Margin
0.00%
-
Return on Assets (ttm)
-387.49%
-
Return on Equity (ttm)
--
-
Revenue (ttm)
--
-
Net Income Avi to Common (ttm)
-9.14M
-
Diluted EPS (ttm)
-0.0400
Balance Sheet and Cash Flow
-
Total Cash (mrq)
1.2M
-
Total Debt/Equity (mrq)
--
-
Levered Free Cash Flow (ttm)
-2.87M
Compare
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
0.2200
+30.95%
Mkt Cap
EUR
29.932M
Industry
Drug Manufacturers—Specialty & Generic
7.79
-2.87%
Mkt Cap
1.991B
Industry
Drug Manufacturers—Specialty & Generic
28.07
-4.46%
Mkt Cap
6.549B
Industry
Drug Manufacturers—Specialty & Generic
